Linked Life Data

10834962

Source:http://linkedlifedata.com/resource/pubmed/id/10834962

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10834962rdf:typepubmed:Citationlld:pubmed
pubmed-article:10834962lifeskim:mentionsumls-concept:C0025344lld:lifeskim
pubmed-article:10834962lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:10834962lifeskim:mentionsumls-concept:C0701159lld:lifeskim
pubmed-article:10834962lifeskim:mentionsumls-concept:C0085494lld:lifeskim
pubmed-article:10834962lifeskim:mentionsumls-concept:C0204727lld:lifeskim
pubmed-article:10834962lifeskim:mentionsumls-concept:C0205409lld:lifeskim
pubmed-article:10834962lifeskim:mentionsumls-concept:C2347804lld:lifeskim
pubmed-article:10834962lifeskim:mentionsumls-concept:C1561960lld:lifeskim
pubmed-article:10834962lifeskim:mentionsumls-concept:C1880022lld:lifeskim
pubmed-article:10834962lifeskim:mentionsumls-concept:C1948053lld:lifeskim
pubmed-article:10834962pubmed:issue6lld:pubmed
pubmed-article:10834962pubmed:dateCreated2000-7-26lld:pubmed
pubmed-article:10834962pubmed:abstractTextIn February 1996, a Hospital Infection Control Practices Advisory Committee-style screening program was commenced to isolate and subsequently characterize glycopeptide-resistant enterococci (GRE) from patients at a hospital trust in Glasgow, Scotland. Over the next 30 months, GRE were isolated from 154 patients. GRE were isolated from patients in traditionally high-risk areas such as the renal unit and intensive care unit and also in areas considered to be lower risk, including medical wards and associated long-stay geriatric hospitals. The majority (90%) of isolates were Enterococcus faecium vanB. The remaining isolates consisted of seven E. faecalis (vanA), three E. gallinarum (vanC), and a further six E. faecium (five vanA, one both vanA and vanB) isolates. Analysis of SmaI-digested DNA by pulsed-field gel electrophoresis revealed that 34 of 40 (85%) VanB E. faecium isolates were identical or closely related, while 11 of 13 (85%) VanA GRE were distinct. High-level aminoglycoside resistance was seen in less than 8% of isolates. VanB E. faecium isolates were almost uniformly resistant to ampicillin and tetracycline. In this study, GRE have been isolated over a prolonged period from a broad range of patients. Glycopeptide resistance within the study hospital trust appeared to be mainly due to the clonal dissemination of a single strain of E. faecium VanB.lld:pubmed
pubmed-article:10834962pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10834962pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10834962pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10834962pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10834962pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10834962pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10834962pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10834962pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10834962pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10834962pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10834962pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10834962pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10834962pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10834962pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10834962pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10834962pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10834962pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10834962pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10834962pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10834962pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10834962pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10834962pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10834962pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10834962pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10834962pubmed:languageenglld:pubmed
pubmed-article:10834962pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10834962pubmed:citationSubsetIMlld:pubmed
pubmed-article:10834962pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10834962pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10834962pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10834962pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10834962pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10834962pubmed:statusMEDLINElld:pubmed
pubmed-article:10834962pubmed:monthJunlld:pubmed
pubmed-article:10834962pubmed:issn0095-1137lld:pubmed
pubmed-article:10834962pubmed:authorpubmed-author:AmyesS GSGlld:pubmed
pubmed-article:10834962pubmed:authorpubmed-author:NelsonR RRRlld:pubmed
pubmed-article:10834962pubmed:authorpubmed-author:YoungHHlld:pubmed
pubmed-article:10834962pubmed:authorpubmed-author:BrownA RARlld:pubmed
pubmed-article:10834962pubmed:authorpubmed-author:McGregorK FKFlld:pubmed
pubmed-article:10834962pubmed:issnTypePrintlld:pubmed
pubmed-article:10834962pubmed:volume38lld:pubmed
pubmed-article:10834962pubmed:ownerNLMlld:pubmed
pubmed-article:10834962pubmed:authorsCompleteYlld:pubmed
pubmed-article:10834962pubmed:pagination2112-6lld:pubmed
pubmed-article:10834962pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:10834962pubmed:meshHeadingpubmed-meshheading:10834962...lld:pubmed
pubmed-article:10834962pubmed:meshHeadingpubmed-meshheading:10834962...lld:pubmed
pubmed-article:10834962pubmed:meshHeadingpubmed-meshheading:10834962...lld:pubmed
pubmed-article:10834962pubmed:meshHeadingpubmed-meshheading:10834962...lld:pubmed
pubmed-article:10834962pubmed:meshHeadingpubmed-meshheading:10834962...lld:pubmed
pubmed-article:10834962pubmed:meshHeadingpubmed-meshheading:10834962...lld:pubmed
pubmed-article:10834962pubmed:meshHeadingpubmed-meshheading:10834962...lld:pubmed
pubmed-article:10834962pubmed:meshHeadingpubmed-meshheading:10834962...lld:pubmed
pubmed-article:10834962pubmed:meshHeadingpubmed-meshheading:10834962...lld:pubmed
pubmed-article:10834962pubmed:meshHeadingpubmed-meshheading:10834962...lld:pubmed
pubmed-article:10834962pubmed:meshHeadingpubmed-meshheading:10834962...lld:pubmed
pubmed-article:10834962pubmed:meshHeadingpubmed-meshheading:10834962...lld:pubmed
pubmed-article:10834962pubmed:meshHeadingpubmed-meshheading:10834962...lld:pubmed
pubmed-article:10834962pubmed:year2000lld:pubmed
pubmed-article:10834962pubmed:articleTitleIsolation and characterization of glycopeptide-resistant enterococci from hospitalized patients over a 30-month period.lld:pubmed
pubmed-article:10834962pubmed:affiliationDepartment of Clinical Microbiology, Western Infirmary, Glasgow, United Kingdom.lld:pubmed
pubmed-article:10834962pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10834962pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10834962lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10834962lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10834962lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10834962lld:pubmed